| Cell line name |
HCT 116 EP300 WT |
| Synonyms |
HCT 116 p300 WT |
| Accession |
CVCL_HG26 |
| Resource Identification Initiative |
To cite this cell line use: HCT 116 EP300 WT (RRID:CVCL_HG26) |
| Comments |
Population: Caucasian. Characteristics: HCT 116 is hemizygous for EP300. This cell line is a normal derivative of HCT 116 from which a number of clones KO for the EP300 single allele were established. Derived from site: In situ; Colon; UBERON=UBERON_0001155. |
| Sequence variations |
- Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
|
| Disease |
Colon carcinoma (NCIt: C4910) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Hierarchy |
Parent: CVCL_0291 (HCT 116) Children:
|
| Sex of cell |
Male |
| Age at sampling |
48Y |
| Category |
Cancer cell line |
| STR profile |
Source(s): ECACC=17011214
Markers:| Amelogenin | X |
| CSF1PO | 7,10 |
| D3S1358 | 12.1,18.1 |
| D5S818 | 10,11 |
| D7S820 | 11,12 |
| D8S1179 | 10.1,14.1 |
| D13S317 | 10,13 |
| D16S539 | 11,13 |
| D18S51 | 16,17 |
| D21S11 | 29,30 |
| FGA | 18,23 |
| Penta D | 9,13 |
| Penta E | 13,14 |
| TH01 | 8,9 |
| TPOX | 8 |
| vWA | 17,22 |
Run an STR similarity search on this cell line |
| Publications | PubMed=15123817; DOI=10.1073/pnas.0401002101; PMCID=PMC409928 N. Gopalakrishna Iyer, Suet-Feung Chin, Hilal Ozdag, Yataro Daigo, De-En Hu, Massimiliano Cariati, Kevin Michael Brindle, Samuel Aparicio, Carlos Caldas; p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc. Natl. Acad. Sci. U.S.A. 101:7386-7391(2004) |
| Cross-references |
| Cell line collections (Providers) |
CancerTools; 153183
ECACC; 17011214 - Discontinued
Ximbio; 153183
|
| Cell line databases/resources |
cancercelllines; CVCL_HG26
|
| Encyclopedic resources |
Wikidata; Q54881933
|
| Entry history |
| Entry creation | 01-Dec-2016 |
| Last entry update | 19-Dec-2024 |
| Version number | 17 |
|---|